is there a patent on semaglutide Last week's expiry of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed flurry of launches of low-cost generic versions Natco beats rivals with Rs

Is Retatrutide for human or animal use

The degree of weight loss depends on your genetics, the steroid dose and duration, your baseline metabolism, and how well you respond to GLP-1 therapy

Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y (2022) Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial

Nothing unusual here, but understanding each step helps set realistic expectations

Timeline of changes in appetite during weight loss with a ketogenic diet